KRP-109 is a neutrophil elastase (NE) inhibitor with activity in reducing lung inflammation. KRP-109 improves survival in mouse models and reduces the number of neutrophils and inflammation in the alveolar walls. KRP-109 significantly reduced cell and neutrophil counts in bronchoalveolar lavage fluid, as well as cytokine levels such as interleukin 1beta and macrophage inflammatory protein 2. KRP-109 can be used in the research of severe pneumonia[1].
Molecular Weight:
510.54
CAS Number:
[1275996-50-3]
Formula:
C26H30N4O7
Target:
Endogenous Metabolite
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
